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Small ubiquitin-like modiﬁer-1/2/3 (SUMO-1/2/3) and ubiquitin share similar structure and
utilize analogousmachinery for protein lysine conjugation.Although sumoylation and ubiqui-
tylation have distinct functions, they are often tightly associatedwith each other to ﬁne-tune
protein fate in transducing signals to regulate a wide variety of cellular functions, including
DNA damage response, cell proliferation, DNA replication, embryonic development, and
cell differentiation. In this Perspective, we speciﬁcally highlight the role of sumoylation
and ubiquitylation in ataxia-telangiectasia mutated (ATM) signaling in response to DNA
double-strand breaks and hypothesize that ATM-induced phosphorylation is a unique node
in regulating SUMO-targeted ubiquitylation in mammalian cells to combat DNA damage
and to maintain genome integrity. A potential role for the coordination of three types of
post-translational modiﬁcation in dictating the tempo and extent of cellular response to
genotoxic stress is speculated.
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Small ubiquitin-like modiﬁer (SUMO) and ubiquitin (Ub) can be
post-translationally attached to their target proteins. They share
less than 20% identity of amino acid sequence; however, their
structure and biochemical machinery catalyzing the modiﬁcation
are similar. Sumoylation and ubiquitylation are known to function
distinctly in operating the fate of protein. Sumoylation is to con-
duct signals for nuclear translocation, transcriptional repression
and protein recruitment, whereas lysine (Lys)-48-linked polyu-
biquitylation is a common mark for protein degradation in pro-
teasome; Lys-63 linkage of Ub directs protein trafﬁcking. Both
SUMO and Ub participate in regulating a wide range of cellular
functions, including DNA damage response (DDR), cell growth,
differentiation, and development (Gill, 2004; Denuc and Marfany,
2010; Tang and Greenberg, 2010; Praefcke et al., 2011). Here, we
speciﬁcally focus on the role of sumoylation and ubiquitylation in
DDR.
DNA damage response is an evolved mechanism for cells to
confront DNA lesions generated by endogenous or environmen-
tal agents. The cells sense DNA lesions, such as DNA double-
strand breaks (DSB), mismatches, and bulky adducts to subse-
quently induce signaling pathways promoting cell cycle arrest,
DNA repair, apoptosis, transcription, and chromatin remodel-
ing (Jackson and Bartek, 2009). A large protein kinase family,
phosphoinositide 3 kinase-like protein kinases (PIKKs) including
ataxia-telangiectasia mutated (ATM), ataxia-telangiectasia, and
Rad3 related (ATR), and DNA-dependent protein kinase catalytic
subunit (DNA-PKcs), participates in DDR by phosphorylating a
subset of target proteins to regulate cellular functions andmaintain
genome integrity. DefectiveDDR causes the accumulation of DNA
lesions and eventually leads to genome instability, a hallmark of
cancer. Particularly, ATM plays a primary role in transducing DSB
signal to a broad spectrum of proteins involved in DNA repair,
cell cycle checkpoints, and apoptosis (Shiloh, 2003). Mutations
at the ATM locus thereby elicit phenotypes reﬂective of defects
in cell cycle regulation and apoptosis. Ataxia telangiectasia (A-T)
patients are extremely sensitive to ionizing radiation, such as X-
and γ-rays (Lavin, 2008).A-T cells do not exhibit cell cycle arrest at
regular checkpoints when stressed by irradiation (Morrison et al.,
2000). Distinct mutations of the ATM gene also predispose some
patients to cancer, particularly lymphoma cancers in 30% of A-
T patients and leukemia (Hunter, 2007; Lavin, 2008). Therefore,
studies of ATM-regulated pathways in conjunction with DDR
are crucial to understanding maintenance of genome integrity.
Particularly, in this Perspective, we review multiple types of post-
translational modiﬁcation (PTM): phosphorylation, sumoylation,
ubiquitylation, and their combinatorial effects in ATM signaling
pathways.
ATM-REGULATED SUMOYLATION IN DDR
Sumoylation regulates ATM-mediated DNA damage signaling in
both transcription and chromatin remodeling. A unique example
that well-illustrates the relationship between ATM-induced phos-
phorylation and sumoylation is Krüppel-associated box (KRAB)-
associated protein 1 (KAP1; also known as TRIM28 and TIF1β).
KAP1 is a transcriptional co-repressor primarily responding to
DNA damage and regulating cellular functions such as checkpoint
control and apoptosis (Lee et al., 2007; Li et al., 2007). KAP1 has six
putative sumoylation sites and its sumoylation at Lys-779 and Lys-
804 are required for the interaction with chromatin remodelers
including heterochromatin protein 1(HP1), SET domain, bifur-
cated 1 (SETDB1), nucleosome remodeling deacetylase (NuRD),
and histone deacetylases (HDACs) to establish a silent state of
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chromatin and to repress transcription (Ryan et al., 1999; Schultz
et al., 2001, 2002; Sripathy et al., 2006; Ivanov et al., 2007; Lee
et al., 2007). When cells are exposed to genotoxic stress, DSBs acti-
vate ATM to phosphorylate KAP1 at serine (Ser)-824 and result
in a decrease of SUMO–KAP1 population, leading to the de-
repressionof KAP1-regulatedDNAdamage-responsive genes:p21,
GADD45α, BAX, NOXA, and PUMA (White et al., 2006; Lee et al.,
2007; Li et al., 2007). Furthermore, phosphorylation/sumoylation
switch on KAP1 has been illuminated through research in protein
phosphatases 1α and 1β (PP1α and PP1β). While PP1α directly
interacts with KAP1 under basal condition, PP1β interacts with
KAP1 only in response to genotoxic stress. Changes in the abun-
dance of PP1α and PP1β have differential effects on phosphoryla-
tion and sumoylation of KAP1 under both unstressed and stressed
conditions (Li et al., 2010). Although the underlying mechanism
of phosphorylation-induced decrease of SUMO–KAP1 is still not
clear, possibilities might include that ATM-induced phosphory-
lation activates SUMO proteases to de-sumoylate KAP1 or that
ATM triggers the degradation of SUMO–KAP1.
Besides of transcriptional regulation, KAP1 also participates in
chromatin conﬁguration. Chromodomain helicase DNA binding
protein 3 (CHD3; also known as Mi2α) interacts with SUMO–
KAP1 through its SUMO-interacting motif (SIM). The binding
of KAP1 and CHD3 conﬁgures KAP1-associated chromatin into a
compact structure. Upon DNA damage, ATM-induced phospho-
rylation at Ser-824 of KAP1 interrupts the SUMO:SIM interaction
between KAP1 and CHD3, leading to the relaxation of chromatin
which is more accessible for DNA repair modules to come in to
the damage sites and repair the lesions (Goodarzi et al., 2011).
Although very few reports demonstrate the connection between
ATM signaling and protein sumoylation, in the KAP1 case, the
control of phosphorylation/sumoylation switch on KAP1 seems to
play an indispensable role in transducing ATM signal. The switch
on KAP1 has to be tightly regulated in order to respond to DNA
damage and return to the basal state in a timely and proper way.
ATM-REGULATED UBIQUITYLATION IN DDR
Ubiquitylation serves as a critical signal for recruiting DNA repair
machinery to the damage sites. Upon DNA damage, MRE11–
Rad50–NBS1 (MRN) complex recognizes and processes the end
of DSBs (Uziel et al., 2003). ATM is then recruited to phosphory-
late H2AX at Ser-139, creating a docking site for the mediator of
DNA damage checkpoint protein 1 (MDC1) to be recruited to the
DNA damage foci. ATM further phosphorylates MDC1 in order to
recruit ring ﬁnger protein 8 (RNF8)–HERC2–UBC13 complex to
the foci to catalyze Lys-63 polyubiquitylation of H2A (Lou et al.,
2006; Huen et al., 2007; Kolas et al., 2007; Bekker-Jensen et al.,
2010). RNF168 is subsequently recruited to the Lys-63 polyubiq-
uitylated H2A and ampliﬁes Lys-63-linked poly Ub chains on H2A
and H2AX around the foci (Doil et al., 2009). Meanwhile, RNF8
also catalyzes Lys-48 polyubiquitylation on the client proteins at
damage sites. The Lys-48 polyubiquitylated substrates will then
be turned over by recruiting p97-UFD1–NPL4 Ub-selective seg-
regase (Meerang et al., 2011). The coordination of these signals
ultimately recruits BRCA1–RAP80 complex, 53BP1, and Rad51 to
facilitate DSB repair and checkpoint arrest (Kolas et al., 2007; Doil
et al., 2009; Bekker-Jensen et al., 2010; Meerang et al., 2011). After
repairing the damage, the removal of H2AX from the damage
sites involves an acetylation-dependent ubiquitylation catalyzed
by TIP60–UBC13 complex (Ikura et al., 2007).
Other than transducing signals to recruit repair proteins,
ATM also represses transcription in cis to DSBs by establishing
monoubiquitylation of H2A to inhibit RNA polymerase II func-
tion. Since monoubiquitylation at Lys-119 of H2A (uH2A) is
associated with transcriptional repression, ATM-mediated tran-
scriptional silencing was explored in tandem with uH2A. By
inhibiting ATM, uH2A levels at DSBs are signiﬁcantly decreased
although the Lys-63-linked poly Ub chains and RAP80 levels
around the foci are less affected. ATM therefore plays a critical
role in maintenance of uH2A at DSBs through RNF8/RNF168,
while the Lys-63-linked poly Ub chains serve as separate docking
sites for recruitment of repair proteins such as BRCA1 com-
plex. Furthermore,ATM-dependent uH2A stalls RNA polymerase
II-mediated transcription in cis to the damage site. A deubiq-
uitylation enzyme, USP16, negatively regulates uH2A-dependent
function and rapidly restores transcription after the cessation of
DNA damage (Shanbhag et al., 2010).
Ataxia-telangiectasia mutated-induced phosphorylation also
exhibits crosstalk with ubiquitylation by mediating protein degra-
dation through direct and indirect recruitment of Ub E3 ligases. In
the case of the tumor suppressor p53,ATM-induced phosphoryla-
tion participates in the dual function of repressing and promoting
the ubiquitylation of different effectors, leading to their degrada-
tion. p53 induces transcription of multiple genes important for
cell cycle regulation, DNA repair, and apoptosis. ATM phosphory-
lates p53 at Ser-15, leading to transcription of the CDK2/cyclin-E
inhibitor which functions at the G1-S checkpoint (Shiloh, 2003).
ATM-inducedphosphorylation inhibits negative regulators of p53,
including MDM2 and constitutive morphogenic 1 (COP1). Both
MDM2 and COP1 are Ub E3 ligases that ubiquitylate p53 to
promote its proteasomal degradation. ATM indirectly regulates
MDM2-mediated degradation of p53 through phosphorylation
of Chk2 which then phosphorylates p53 at Ser-20 to prevent the
formation of the MDM2–p53 complex (Dumaz et al., 2001). ATM
also directly phosphorylates MDM2 at Ser-395 to prevent the
export of the MDM2–p53 complex into the cytoplasm, thereby
maintaining p53 in the nucleus (Maya et al., 2001; Chen et al.,
2005). In addition, phosphorylation of COP1 by ATM induces
autoubiquitylation of COP1 (Dornan et al., 2006). ATM phospho-
rylation thus selectively inﬂuences the repression and activation of
ubiquitylation on different proteins in response to DNA damage.
Taken together, ATM-induced phosphorylation in coordination
with ubiquitylation plays an essential role in establishing a series
of signals directing to transcriptional regulation, the completion
of DSB repair and in determining the fate of key proteins involved
in DDR.
CROSSTALK BETWEEN SUMOYLATION AND
UBIQUITYLATION IN DDR
The convergence of sumoylation and ubiquitylation does take
place under genotoxic condition. When DSBs occur, protein
inhibitor of activated signal transducer and activator of tran-
scription (PIAS) localizes to the damage sites. PIAS1 and PIAS4
function as SUMOE3 ligase tomodify BRCA1,53BP1 andpossibly
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RNF8,RNF168 tomodulate their activities in facilitatingUb signal
ampliﬁcation and DNA repair after genotoxic stress (Galanty et al.,
2009). Sumoylation on BRCA1 increases its Ub E3 ligase activity,
therefore termed as a SUMO-regulated Ub ligase (SRUbL; Morris
et al., 2009). It is still not clear how PIAS activity is regulated under
DNA damage condition, and whether this is dependent on ATM-
induced phosphorylation. PIAS1 is phosphorylated by IκB kinase
alpha (IKKα; Liu et al., 2007), whose activity is also regulated by
ATM-dependent NF-κB essential modulator (NEMO) ubiquity-
lation (Wuerzberger-Davis et al., 2006), implying that the role of
PIAS in DDR might also be incorporated into ATM signaling.
Another interesting example showing the interplay between
sumoylation and ubiquitylation in the context of genotoxic stress
is SUMO-targeted ubiquitin ligase (STUbL), including Slx8–Rfp,
MIP1, Slx5–Slx8, and RNF4. It is a new class of ubiquitin E3 ligases
targeting sumoylated proteins through their SIMs for ubiquity-
lation. STUbL has been reported to trigger the degradation of
sumoylated proteins and is responsible for the maintenance of cell
survival and genome stability (Lallemand-Breitenbach et al., 2008;
Tatham et al., 2008; Cook et al., 2009; Heideker et al., 2009). For
example, RNF4 (RING ﬁnger protein 4, RING: Really Interesting
New Gene), the only human homolog of Slx8–Rfp, is involved in
arsenic-trioxide (ATO)-induced polyubiquitylation and proteaso-
mal degradation of promyelocytic leukemia (PML) by targeting
the poly SUMO-2 chain on PML (Lallemand-Breitenbach et al.,
2008; Tatham et al., 2008). This reveals the role of RNF4 in mediat-
ing the crosstalk between sumoylation and ubiquitylation and also
provides a possible mechanism of ATO-induced damage response.
In conclusion, crosstalk between sumoylation and ubiquitylation
seems like a general scenario in DDR; however, it is still not fully
understood how this crosstalk might be modulated and sinceATM
signaling requires sumoylation and ubiquitylation to respond to
DSB, it is possible that ATM is involved in tuning SUMO–Ub
crosstalk through RNF4 in DDR.
IS RNF4 INVOLVED IN ATM SIGNALING?
Given to the fact that RNF4 biologically functions as an important
factor for maintaining genome integrity and its ability to recognize
and possibly regulate more than 300 substrates involved in a wide
variety of biological processes, including chromatin remodeling
andDNArepair etc. Bruderer et al. (2011),one could speculate that
RNF4 might participate in ATM-regulated DSB damage response.
RNF4 IS EXTENSIVELY INVOLVED IN DNA DAMAGE SIGNALING
PATHWAYS
Yeast homolog of RNF4, Slx5/Slx8 physically associates with DSBs
to form damage foci, in a SUMO and SIM-dependent way (Nagai
et al., 2008; Cook et al., 2009). Slx8 functions with Rad60, a DNA
repair protein, and Nse2, a SUMO ligase to protect the genome
from Topoisomerase-1 (Top-1)-induced DNA damage (Prudden
FIGURE 1 | Sequence alignment of SIMs andARR of RNF4 family members from different organisms. Data here show that four SIM domains and ARR
are conserved throughout evolution.
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et al., 2007; Heideker et al., 2011). Fission yeast Rfp1 and Rfp2
complement one another in regulating defects in cell cycle pro-
gression and Chk1-dependnet DNA repair; moreover, human
RNF4 is able to functionally rescue this phenotype in rfp1/rfp2
double null mutant (Kosoy et al., 2007). RNF4 also functions
speciﬁcally to demethylate DNA by interacting with base exci-
sion repair enzymes TDG and APE1 that target G:T mismatches
in the DNA. In addition, RNF4 deﬁciency displays global DNA
hypermethylation (Hu et al., 2010). Taken together, the biolog-
ical function of RNF4 is conserved and tightly associated with
DDR, especially DNA repair and chromatin remodeling in dif-
ferent organisms, supporting the idea that RNF4 plays a role in
coordinating and transducingATM-induced signaling in response
to DNA damage.
EVIDENCE SUPPORTING PHOSPHORYLATION-INDUCED
SUMO-DEPENDENT PROTEIN DEGRADATION
Promyelocytic leukemia is found to be degraded upon
ATO-treatment and the degradation is dependent on the
phosphorylation-induced by ATO and the subsequent increase
of sumoylation (Lallemand-Breitenbach et al., 2001; Hayakawa
and Privalsky, 2004). ATO-induced sumoylation on Lys-160 is
critical for recruiting RNF4 to ubiquitylate PML for proteaso-
mal degradation (Lallemand-Breitenbach et al., 2001; Petrie and
Zelent, 2008). Although there is no direct link showing phospho-
rylation of PML promotes SUMO-dependent degradation, either
phosphorylation-defective,or sumoylation-defective PMLmutant
shows abolisheddownstreameffects in response toATO-treatment
(Lallemand-Breitenbach et al., 2001; Yang et al., 2002; Hayakawa
and Privalsky, 2004), implying that both modiﬁcations and their
crosstalk are indispensable in leading toATO-induced PML degra-
dation. PML can be phosphorylated by several kinases including
MAPK, CK2, and CHK2 (Yang et al., 2002; Hayakawa and Prival-
sky, 2004; Joe et al., 2006; Scaglioni et al., 2006). Interestingly,
phosphorylation-defective PML is stabilized upon DNA dam-
age triggered by γ-irradiation and results in decreased apoptotic
activity, in an ATM/CHK2-dependent manner (Yang et al., 2002).
Evidence from the PML studies provide some hints supporting
that the degradation promoted by RNF4 is possibly regulated by
phosphorylation; however, it is still unclear how phosphorylation
induces sumoylation of PML and whether there is another mecha-
nism that phosphorylation of PML might enhance the recognition
by RNF4.
UNIQUE STRUCTURAL CHARACTERISTIC OF RNF4 POSSIBLY LINKS
PHOSPHORYLATION, SUMOYLATION AND UBIQUITYLATION
If one speculates that RNF4-mediated SUMO-targeted ubiquity-
lation is regulated by ATM-induced phosphorylation, what would
the mode of regulation be? A unique region is found in RNF4 pro-
tein. Following the four SIMs, there is a region rich with arginine,
named arginine-rich region (ARR) in RNF4 (Figure 1), denoting
that this region provides positive charge to attract phosphory-
lated protein with negative charge. The electrostatic interaction
between arginine and phosphate forms a covalent-like binding
(Woods and Ferre, 2005). Thus, the ARR in RNF4 might enhance
its interaction with target proteins phosphorylated by ATM. In
summary, phosphorylation on RNF4 target proteins might be a
mode to regulate RNF4-mediated, SUMO-targeted ubiquitylation
and related biological function.
A POTENTIAL MECHANISM OF RNF4 TARGETING ATM SUBSTRATES
FOR PROTEASOMAL DEGRADATION
It was noted that phosphorylation and subsequent sumoylation
of PML occur within 1 h after treating with ATO (Lallemand-
Breitenbach et al., 2001; Hayakawa and Privalsky, 2004); however,
signiﬁcant degradation of PML is observed around 12–16 h after
ATO-treatment (Lallemand-Breitenbach et al., 2001, 2008), indi-
cating that the regulation of RNF4-mediated PML degradation
might be in slow kinetics. This suggests that there might be
other factors required for targeting RNF4-ubiquitylated PML to
FIGURE 2 | Proposed schematic showing the crosstalk of
phosphorylation, sumoylation, and ubiquitylation in ATM-regulated
signaling in response to DNA damage. Double-strand breaks activate
ATM to induce downstream signaling cascade involving sumoylation and
ubiquitylation of proteins participating in DNA damage response, such as
checkpoint control and DNA repair. STUbL functions as a signal transducer
to coordinate SUMO and Ub signals to catalyze SUMO-targeted
ubiquitylation, which may recruit p97–UFD1–NPL4 segregase complex to
mediate the proteasomal degradation.
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proteasome. An AAA-ATPase p97, its adaptors UFD1 and NPL4
are implicated in recognizing and extracting polyubiquitylated
proteins to proteasome for degradation in various cellular con-
text, includingmitosis,DNA replication, andDNAdamage (Richly
et al., 2005; Ramadan et al., 2007; Mouysset et al., 2008; Meerang
et al., 2011; Verma et al., 2011). To explain the observation of
slow degradation of PML, rather than rapid turnover, in our view,
RNF4 may serve as a signal transducer that senses SUMO sig-
nal and ampliﬁes Ub signal on its substrates to recruit selective
cargo proteins, such as p97–UFD1–NPL4 complex to extract the
ubiquitylated substrates for proteasomal degradation.
CONCLUSION AND PERSPECTIVE
Sumoylation and ubiquitylation widely participate in ATM-
regulated DDR. When cells are exposed to genotoxic stress, DSBs
activate ATM to phosphorylate a subset of target proteins to
transduce signals and to induce checkpoint control and DNA
repair machinery. This process largely involves the cooperation
of sumoylation and ubiquitylation to regulate cellular function
in response to DSB. However, little is known about the detailed
mechanism of SUMO–Ub crosstalk. Here, we hypothesize that
RNF4 plays a central role in recognizing ATM-induced phospho-
rylation and sumoylation to provide an additional Ub signal to
recruit Ub-selective segregase to target for proteasomal degrada-
tion (Figure 2). This provides a novel view on the crosstalk among
multiple PTMs. The crosstalk of phosphorylation, sumoylation,
and ubiquitylation denotes a cooperative network in protect-
ing cells from DNA damage and maintaining genome integrity.
Defects in this network may lead to genome instability and
consequently tumorigenesis. Moreover, modulation of the play-
ers involved in the network may sensitize cancer cells to DNA
damage-based cancer therapy and beneﬁt the patients.
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